Journal of Cardiothoracic and Vascular Anesthesia
Volume 17, Issue 1 , Pages 51-59 , February 2003

Comparison of three remifentanil dose-finding regimens for coronary artery surgery

References 

  1. Bovill JG, Warren PJ, Schuller JL, et al.  Comparison of fentanyl, sufentanil, and alfentanil anesthesia in patients undergoing valvular heart surgery. Anesth Analg. 1984;63:1081–1086
  2. Hall RI. The pharmacokinetic behavior of opioids administered during cardiac surgery. Can J Anaesth. 1991;38:747–756
  3. Bovill JG, Sebel PS, Stanley TH. Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia. Anesthesiology. 1984;61:731–755
  4. Cartwright P, Prys-Roberts C, Gill K, et al.  Ventilatory depression related to plasma fentanyl concentrations during and after anesthesia in humans. Anesth Analg. 1983;62:966–974
  5. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 1991;74:53–63
  6. Cheng DC. Pro: early extubation after cardiac surgery decreases intensive care unit stay and cost. J Cardiothorac Vasc Anesth. 1995;9:460–464
  7. Karski JM. Practical aspects of early extubation in cardiac surgery. J Cardiothorac Vasc Anesth. 1995;9(suppl 1):30–33
  8. Foster GH, Conway WA, Pamulkov N, et al.  Early extubation after coronary artery bypass: Brief report. Crit Care Med. 1984;12:994–996
  9. Gall SA. Olsen CO, Reves JG, et al: Beneficial effects of endotracheal extubation on ventricular performance. J Thorac Cardiovasc Surg. 1988;95:819–827
  10. James MK, Feldman PL, Schuster SV, et al.  Opioid receptor activity of GI87084B, a novel ultra-short-acting analgesic, in isolated tissues. J Pharmacol Exp Ther. 1991;259:712–718
  11. Feldman PL, James MK, Brackeen MF, et al.  Design, synthesis and pharmacological evaluation of ultrashort- to long-acting opioid analgesics. J Med Chem. 1991;34:2202–2208
  12. Michelsen LG, Salmenpera M, Hug CC, et al.  Anesthetic potency of remifentanil in dogs. Anesthesiology. 1996;84:865–872
  13. Glass PSA, Hardman D, Kamiyama Y, et al.  Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg. 1993;77:1031–1040
  14. Cunningham FE, Hoke JF, Muir KT, et al.  Pharmacokinetic/pharmacodynamic evaluation of remifentanil, GR90291, and alfentanil. Anesthesiology. 1995;83:376A
  15. Westmoreland CL, Hoke JF, Sebel PS, et al.  Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology. 1993;79:893–903
  16. Egan TD, Lemmens HJM, Fiset P, et al.  The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993;79:881–892
  17. Ausems ME, Vuyk J, Hug CC, Stanski DR. Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery. Anesthesiology. 1988;68:851–861
  18. Hogue CW, Bowdle TA, O'Leary CE, et al.  A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg. 1996;83:279–285
  19. Sebel PS, Hoke JF, Westmoreland C, et al.  Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg. 1995;80:990–993
  20. Wynands JE, Townsend GE, Wong P. Blood pressure response and plasma fentanyl concentrations during high- and very high-dose fentanyl anesthesia for coronary artery surgery. Anesth Analg. 1983;62:661–665
  21. Hall RI, Moldenhauer CC, Hug CC. Fentanyl plasma concentrations maintained by a simple infusion scheme in patients undergoing cardiac surgery. Anesth Analg. 1993;76:957–963
  22. Thomson IR, Henderson BT, Singh K, Hudson RJ. Concentration-response relationships for fentanyl and sufentanil in patients undergoing coronary artery bypass grafting. Anesthesiology. 1998;89:852–861
  23. Edde RR. Hemodynamic changes prior to and after sternotomy in patients anesthetized with high-dose fentanyl. Anesthesiology. 1981;55:444–446
  24. Sebel PS, Bovill JG, Schellekens APM, Hawker CD. Hormonal effects of high-dose fentanyl anesthesia: A study in patients undergoing cardiac surgery. Br J Anaesth. 1981;53:941–948
  25. Parsons RS, Jones RM, Wrigley SR, et al.  Comparison of desflurane and fentanyl-based anaesthetic techniques for coronary artery bypass surgery. Br J Anaesth. 1994;72:430–438
  26. Hug CC. Does opioid “anesthesia” exist?. Anesthesiology. 1990;73:1–4
  27. Philbin DM, Rosow CE, Schneider RC, et al.  Fentanyl and sufentanil anesthesia revisited: how much is enough?. Anesthesiology. 1990;73:5–11
  28. Stanley TH, Berman L, Green O, Robertson D. Plasma catecholamines and cortisol responses to fentanyl-oxygen anesthesia for coronary artery operations. Anesthesiology. 1980;53:250–253
  29. de Lange S, Stanley TH, Boscoe MJ, et al.  Catecholamine and cortisol responses to sufentanil-O2 and alfentanil-O2 anesthesia during coronary artery surgery. Can Anaesth Soc J. 1983;30:248–254
  30. Howie MB, McSweeney TD, Lingam RP, Maschke SP. A comparison of fentanyl-O2 and sufentanil-O2 for cardiac anesthesia. Anesth Analg. 1985;64:877–887
  31. Sanford TJ, Smith NT, Dec-Siver H, Harrison WK. A comparison of morphine, fentanyl, and sufentanil anesthesia for cardiac surgery: Induction, emergence, and extubation. Anesth Analg. 1986;65:259–266
  32. Howie MB, Smith DF, Reilley TE, et al.  Postoperative course after sufentanil or fentanyl anesthesia for coronary artery surgery. J Cardiothorac Vasc Anesth. 1991;5:485–489
  33. Mora CT, Dudek C, Torjman MC, White PF. The effects of anesthetic technique on the hemodynamic and recovery profile in coronary revascularization patients. Anesth Analg. 1995;81:900–910
  34. Cheng DC, Karski J, Peniston C, et al.  Morbidity outcome in early versus conventional tracheal extubation after coronary artery bypass grafting: A prospective randomized controlled trial. J Thorac Cardiovasc Surg. 1996;112:755–764
  35. Quasha AL, Loeber W, Freeley TW, et al.  Postoperative respiratory care: A controlled trial of early and late extubation following coronary artery bypass grafting. Anesthesiology. 1980;52:135–141
  36. Slogoff S, Keats AS. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology. 1989;70:178–188
  37. Guarracino F, Bossi A, Tedesco M, et al.  Remifentanil/propofol anaesthesia for myocardial revascularisation: Our preliminary experience. Br J Anaesth. 1998;80(suppl 2):2
  38. Lehmann A, Boldt J, Zeitler C, et al.  Total intravenous anaesthesia with remifentanil and propofol for implantation of cardioverter-defribrillators in patients with severely reduced left ventricular function. J Cardiothorac Vasc Anaesth. 1999;13:15–19
  39. Olivier P, Sirieix D, Dassier P, et al.  Continuous infusion of remifentanil and target-controlled infusion of propofol for patients undergoing cardiac surgery: A new approach for scheduled early extubation. J Cardiothorac Vasc Anesth. 2000;14:29–35
  40. Howie MB, Cheng D, Newman MF, et al.  A randomised double-blind multicenter comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery. Anesth Analg. 2001;92:1084–1093
  41. Cheng DCH, Newman MF, Duke P, et al.  The efficacy and resource utilization of remifentanil and fentanyl in fast-track coronary artery bypass surgery: A prospective randomised, double-blinded controlled, multi-center trial. Anesth Analg. 2001;92:1094–1102

☆ Supported by a grant from GlaxoWellcome Inc., Middlesex, United Kingdom.

☆☆ Address reprint requests to Michael B. Howie, MD, Department of Anesthesiology, The Ohio State University Hospitals, Columbus, OH 43210.

PII: S1053-0770(02)47710-5

doi: 10.1053/jcan.2003.10

Journal of Cardiothoracic and Vascular Anesthesia
Volume 17, Issue 1 , Pages 51-59 , February 2003

Article Tools

* Image Usage & Resolution